Joel M. Baumgartner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Joel M. Baumgartner has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Martin D. McCarter
Department of Surgery, University of Colorado Denver, Denver, Colorado
3 shared publications- Anirban Banerjee
Department of Surgery, University of Colorado Denver, Aurora; †Department of Surgery, Denver Health Medical Center, Denver; ‡Trauma Research Center and §Department of Pediatrics, University of Colorado Denver, Aurora; and ∥Research Department, Bonfils Blood Center, Denver, Colorado
1 shared publication Brent E. Palmer
Department of Medicine, Division of Allergy and Clinical Immunology, University of Colorado Denver, Denver, Colorado
1 shared publicationCara C. Wilson
Department of Medicine, Division of Infectious Disease, University of Colorado Denver, Denver, Colorado
1 shared publicationChristopher C. Silliman
Department of Pediatrics, University of Colorado, Denver
1 shared publicationDon A. Richter
Department of Surgery, University of Colorado Denver, Denver, Colorado
1 shared publication
Latest Publications
- 1 June 2009
- Published by SAGE Publications in Journal of Interferon & Cytokine Research
- Vol. 29 (6) , 333-338
Red Blood Cell Supernatant Potentiates LPS-Induced Proinflammatory Cytokine Response From Peripheral Blood Mononuclear Cells
Allogeneic blood transfusion has an immunomodulatory capacity on its recipients through accumulation of immunologically active substances with blood storage, and prestorage leukoreduction reduces many of these mediators. We investigated lipopolysaccharide (LPS)-induced cytokine response of peripheral blood mononuclear cells (PBMCs) exposed to packed red blood cell (PRBC) supernatants from leukoreduced (LR) or non-leukoreduced (NLR) units with variable duration of storage. PRBC units were collected with or without leukoreduction on Day 0 before routine storage. The plasma fraction (supernatant) was isolated from LR and NLR units after 1 day (D1) or 42 days (D42) of storage and exposed to PBMCs versus control media for 24 h, then with LPS for an additional 24 h. Cell supernatants were analyzed for IL-1β, IL-6, IL-8, IL-10, and TNF-α by cytokine bead array. IL-1β, TNF-α, and IL-6 were significantly elevated in PRBC groups versus control. D42 NLR PRBC supernatant significantly increased secretion of IL-1β and IL-6 compared to D1 NLR PRBC supernatant. LR significantly attenuated the cytokine response of IL-1β. Thus, PRBC supernatant potentiates proinflammatory LPS-induced cytokine secretion from PBMCs. This response is accentuated with storage duration and partially attenuated with leukoreduction. These findings may partially explain the immune activation seen clinically after blood transfusion.
- 1 June 2009
- Published by SAGE Publications in Journal of Interferon & Cytokine Research
- Vol. 29 (6) , 333-338
Red Blood Cell Supernatant Potentiates LPS-Induced Proinflammatory Cytokine Response From Peripheral Blood Mononuclear Cells
Allogeneic blood transfusion has an immunomodulatory capacity on its recipients through accumulation of immunologically active substances with blood storage, and prestorage leukoreduction reduces many of these mediators. We investigated lipopolysaccharide (LPS)-induced cytokine response of peripheral blood mononuclear cells (PBMCs) exposed to packed red blood cell (PRBC) supernatants from leukoreduced (LR) or non-leukoreduced (NLR) units with variable duration of storage. PRBC units were collected with or without leukoreduction on Day 0 before routine storage. The plasma fraction (supernatant) was isolated from LR and NLR units after 1 day (D1) or 42 days (D42) of storage and exposed to PBMCs versus control media for 24 h, then with LPS for an additional 24 h. Cell supernatants were analyzed for IL-1β, IL-6, IL-8, IL-10, and TNF-α by cytokine bead array. IL-1β, TNF-α, and IL-6 were significantly elevated in PRBC groups versus control. D42 NLR PRBC supernatant significantly increased secretion of IL-1β and IL-6 compared to D1 NLR PRBC supernatant. LR significantly attenuated the cytokine response of IL-1β. Thus, PRBC supernatant potentiates proinflammatory LPS-induced cytokine secretion from PBMCs. This response is accentuated with storage duration and partially attenuated with leukoreduction. These findings may partially explain the immune activation seen clinically after blood transfusion.
- 1 June 2009
- Published by Elsevier in Journal of Surgical Research
- Vol. 154 (1) , 13-20
Increased Survival From Stage IV Melanoma Associated With Fewer Regulatory T Cells
- 1 June 2009
- Published by Elsevier in Journal of Surgical Research
- Vol. 154 (1) , 13-20
Increased Survival From Stage IV Melanoma Associated With Fewer Regulatory T Cells